(EL) Estee Lauder Companies - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5184391044

Skincare, Makeup, Fragrance, Haircare, Tools

EL EPS (Earnings per Share)

EPS (Earnings per Share) of EL over the last years for every Quarter: "2020-09": 1.44, "2020-12": 2.61, "2021-03": 1.62, "2021-06": 0.78, "2021-09": 1.89, "2021-12": 3.01, "2022-03": 1.9, "2022-06": 0.42, "2022-09": 1.37, "2022-12": 1.54, "2023-03": 0.47, "2023-06": 0.07, "2023-09": 0.11, "2023-12": 0.88, "2024-03": 0.97, "2024-06": 0.64, "2024-09": 0.14, "2024-12": 0.62, "2025-03": 0.65, "2025-06": 0.09, "2025-09": 0.32,

EL Revenue

Revenue of EL over the last years for every Quarter: 2020-09: 3562, 2020-12: 4853, 2021-03: 3864, 2021-06: 3936, 2021-09: 4392, 2021-12: 5539, 2022-03: 4245, 2022-06: 3561, 2022-09: 3930, 2022-12: 4620, 2023-03: 3751, 2023-06: 3609, 2023-09: 3518, 2023-12: 4279, 2024-03: 3940, 2024-06: 3871, 2024-09: 3361, 2024-12: 4004, 2025-03: 3550, 2025-06: 3407, 2025-09: 3481,

Description: EL Estee Lauder Companies October 14, 2025

The Estée Lauder Companies Inc. (NYSE: EL) designs, manufactures, markets and sells a broad portfolio of prestige beauty products-including skin-care, makeup, fragrance and hair-care-through a multi-channel network of department stores, specialty retailers, e-commerce platforms, salons, spas and its own direct-to-consumer stores.

Its brand roster spans high-end labels such as La Mer, Jo Malone London, Tom Ford and Le Labo, alongside mass-prestige names like Clinique, M·A·C, The Ordinary and Aveda, giving the company exposure across price points and consumer segments.

Recent financials show EL generated $17.7 billion in net sales for FY 2023, with a 6 % year-over-year increase driven primarily by a 30 % jump in digital sales and strong growth in anti-aging skin-care. Adjusted EPS rose to $2.57 and gross margins held near 71 %, reflecting pricing power despite inflationary pressure on raw-material costs.

Key macro drivers include rising global demand for premium skin-care, especially in Asia-Pacific, and consumer willingness to pay a premium for sustainability-focused formulations-trends that have historically delivered a 4–5 % premium price premium for “green” product lines.

For a deeper quantitative breakdown of EL’s valuation metrics and scenario analysis, the ValueRay platform offers a useful toolkit.

EL Stock Overview

Market Cap in USD 35,174m
Sub-Industry Personal Care Products
IPO / Inception 1995-11-16

EL Stock Ratings

Growth Rating -19.0%
Fundamental 28.8%
Dividend Rating 47.6%
Return 12m vs S&P 500 18.7%
Analyst Rating 3.11 of 5

EL Dividends

Dividend Yield 12m 1.51%
Yield on Cost 5y 0.63%
Annual Growth 5y 11.83%
Payout Consistency 97.9%
Payout Ratio 83.3%

EL Growth Ratios

Growth Correlation 3m 45.7%
Growth Correlation 12m 63.6%
Growth Correlation 5y -90.9%
CAGR 5y -22.34%
CAGR/Max DD 3y (Calmar Ratio) -0.27
CAGR/Mean DD 3y (Pain Ratio) -0.44
Sharpe Ratio 12m 0.73
Alpha 14.54
Beta 1.157
Volatility 42.07%
Current Volume 1854.1k
Average Volume 20d 3773.5k
Stop Loss 88.4 (-4.8%)
Signal 0.37

Piotroski VR‑10 (Strict, 0-10) 2.5

Net Income (-930.0m TTM) > 0 and > 6% of Revenue (6% = 866.5m TTM)
FCFTA 0.05 (>2.0%) and ΔFCFTA -0.85pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 11.29% (prev 11.19%; Δ 0.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.08 (>3.0%) and CFO 1.60b > Net Income -930.0m (YES >=105%, WARN >=100%)
Net Debt (6.79b) to EBITDA (451.0m) ratio: 15.04 <= 3.0 (WARN <= 3.5)
Current Ratio 1.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (363.3m) change vs 12m ago 1.03% (target <= -2.0% for YES)
Gross Margin 74.19% (prev 72.29%; Δ 1.90pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 71.06% (prev 72.48%; Δ -1.42pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -0.96 (EBITDA TTM 451.0m / Interest Expense TTM 398.0m) >= 6 (WARN >= 3)

Altman Z'' 3.09

(A) 0.08 = (Total Current Assets 6.71b - Total Current Liabilities 5.08b) / Total Assets 19.33b
(B) 0.60 = Retained Earnings (Balance) 11.59b / Total Assets 19.33b
(C) -0.02 = EBIT TTM -381.0m / Avg Total Assets 20.32b
(D) 0.68 = Book Value of Equity 10.46b / Total Liabilities 15.44b
Total Rating: 3.09 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 28.79

1. Piotroski 2.50pt = -2.50
2. FCF Yield 2.49% = 1.25
3. FCF Margin 7.24% = 1.81
4. Debt/Equity 2.31 = 0.29
5. Debt/Ebitda 15.04 = -2.50
6. ROIC - WACC (= -9.71)% = -12.13
7. RoE -22.87% = -2.50
8. Rev. Trend -54.39% = -4.08
9. EPS Trend -16.81% = -0.84

What is the price of EL shares?

As of November 05, 2025, the stock is trading at USD 92.88 with a total of 1,854,092 shares traded.
Over the past week, the price has changed by -5.95%, over one month by +4.76%, over three months by +0.80% and over the past year by +42.39%.

Is Estee Lauder Companies a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Estee Lauder Companies (NYSE:EL) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 28.79 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EL is around 75.88 USD . This means that EL is currently overvalued and has a potential downside of -18.3%.

Is EL a buy, sell or hold?

Estee Lauder Companies has received a consensus analysts rating of 3.11. Therefor, it is recommend to hold EL.
  • Strong Buy: 2
  • Buy: 1
  • Hold: 23
  • Sell: 0
  • Strong Sell: 1

What are the forecasts/targets for the EL price?

Issuer Target Up/Down from current
Wallstreet Target Price 96.2 3.5%
Analysts Target Price 96.2 3.5%
ValueRay Target Price 84.4 -9.1%

EL Fundamental Data Overview November 01, 2025

Market Cap USD = 35.17b (35.17b USD * 1.0 USD.USD)
P/E Forward = 43.6681
P/S = 2.4553
P/B = 8.2766
P/EG = 1.7284
Beta = 1.157
Revenue TTM = 14.44b USD
EBIT TTM = -381.0m USD
EBITDA TTM = 451.0m USD
Long Term Debt = 7.31b USD (from longTermDebt, last fiscal year)
Short Term Debt = 418.0m USD (from shortTermDebt, last quarter)
Debt = 9.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.79b USD (from netDebt column, last quarter)
Enterprise Value = 41.96b USD (35.17b + Debt 9.00b - CCE 2.22b)
Interest Coverage Ratio = -0.96 (Ebit TTM -381.0m / Interest Expense TTM 398.0m)
FCF Yield = 2.49% (FCF TTM 1.04b / Enterprise Value 41.96b)
FCF Margin = 7.24% (FCF TTM 1.04b / Revenue TTM 14.44b)
Net Margin = -6.44% (Net Income TTM -930.0m / Revenue TTM 14.44b)
Gross Margin = 74.19% ((Revenue TTM 14.44b - Cost of Revenue TTM 3.73b) / Revenue TTM)
Gross Margin QoQ = 73.37% (prev 71.97%)
Tobins Q-Ratio = 2.17 (Enterprise Value 41.96b / Total Assets 19.33b)
Interest Expense / Debt = 0.96% (Interest Expense 86.0m / Debt 9.00b)
Taxrate = 56.88% (62.0m / 109.0m)
NOPAT = -164.3m (EBIT -381.0m * (1 - 56.88%)) [loss with tax shield]
Current Ratio = 1.32 (Total Current Assets 6.71b / Total Current Liabilities 5.08b)
Debt / Equity = 2.31 (Debt 9.00b / totalStockholderEquity, last quarter 3.89b)
Debt / EBITDA = 15.04 (Net Debt 6.79b / EBITDA 451.0m)
Debt / FCF = 6.49 (Net Debt 6.79b / FCF TTM 1.04b)
Total Stockholder Equity = 4.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.81% (Net Income -930.0m / Total Assets 19.33b)
RoE = -22.87% (Net Income TTM -930.0m / Total Stockholder Equity 4.07b)
RoCE = -3.35% (EBIT -381.0m / Capital Employed (Equity 4.07b + L.T.Debt 7.31b))
RoIC = -1.44% (negative operating profit) (NOPAT -164.3m / Invested Capital 11.43b)
WACC = 8.27% (E(35.17b)/V(44.18b) * Re(10.28%) + D(9.00b)/V(44.18b) * Rd(0.96%) * (1-Tc(0.57)))
Discount Rate = 10.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.46%
[DCF Debug] Terminal Value 61.08% ; FCFE base≈1.16b ; Y1≈761.7m ; Y5≈348.3m
Fair Price DCF = 21.07 (DCF Value 4.95b / Shares Outstanding 234.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -16.81 | EPS CAGR: -43.52% | SUE: 0.54 | # QB: 0
Revenue Correlation: -54.39 | Revenue CAGR: -9.78% | SUE: 0.05 | # QB: 0

Additional Sources for EL Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle